Jeito Capital
Jeito Capital is a leading global investment company focused on biopharmaceuticals. They finance and accelerate cutting-edge medical innovation with a patient benefit approach, supporting entrepreneurs through significant capital contributions and expert guidance.
📥 Buy Full VC Dataset
Offices: Paris (France)
Investment Stages: Series A, Series B
Markets: Biopharmaceuticals, Oncology, Ophthalmology, Rare Skeletal Diseases, Severe Respiratory Diseases, Fibrosis, Immuno-oncology, Cardiovascular Disease, Immuno-Oncology Therapies, Auto-Immune Diseases, Neuromuscular Diseases, Cell Therapy, Gene Therapy
Founded Year: 2018
Investor Type: Venture Capital
Portfolio Companies: Neogene Therapeutics, Sparing Vision, Pulmocide, Alentis Therapeutics, Quell Therapeutics, Advesya, NMD Pharma, EyeBio, Precirix, CDR-Life, HI-Bio, CatalYm, Noema Pharma, Corteria Pharmaceuticals
Website: https://www.jeito.life/
Team Page: https://www.jeito.life/en/team/
Portfolio Link: https://www.jeito.life/en/portfolio/
LinkedIn: https://www.linkedin.com/company/jeito-life/
Twitter: https://twitter.com/jeito_life
Crunchbase: https://www.crunchbase.com/organization/jeito-capital
Pitchbook: https://pitchbook.com/profiles/investor/279823-24
Comments
No comments yet. Be the first to comment!